The Catalyst for a Cure Vision Restoration Team is exploring and developing novel strategies to protect, repair, and replace lost retinal nerve cells and help them reconnect with the visual brain.
New strategies are needed to rethink how we treat glaucoma to do more than just manage eye pressure — to actually restore vision by promoting the survival of retinal ganglion cells and their axons.
Therapies, treatments, and technologies—No two cases of glaucoma are alike, and the effectiveness of therapies differ but promising new research findings offer reason to be optimistic.
Glaucoma Research Foundation announces a total of $1.7 million in annual research grants to support 13 investigators at prestigious colleges and universities across the United States.
The Shaffer Prize, presented annually by Glaucoma Research Foundation, recognizes a researcher whose project best exemplifies the pursuit of innovative ideas in the quest to cure glaucoma.
The Catalyst for a Cure researchers are a team of four principal investigators and their laboratories working together to restore vision and cure glaucoma.
December 2, 2020 – Harvard Medical School scientists have successfully restored vision in mice by turning back the clock on aged eye cells in the retina to recapture youthful gene function. The team’s work, described December 2nd in Nature, represents the first demonstration that it may be possible to safely reprogram complex tissues, such as the nerve cells of the eye, to an earlier age. In addition to resetting the cells’ aging clock, the researchers successfully
“Being part of Catalyst for a Cure has given me the opportunity to interact with patients, families, and donors, which has been inspiring and motivating.”
The Gleams Newsletter includes interviews, personal stories, and current information about glaucoma, new treatments, updates on research findings, and more. You can subscribe to the printed version of Gleams or the electronic version — both are free.
The Gleams Newsletter includes interviews, personal stories, and current information about glaucoma, new treatments, updates on research findings, and more. You can subscribe to the printed version of Gleams or the electronic version — both are free.
FOR EYECARE PROFESSIONALS
FOR EYECARE PROFESSIONALS
Glaucoma Research Foundation • 251 Post Street, Suite 600 • San Francisco, CA 94108 • 415-986-3162
Send us an email
We are a 501c3 tax-exempt national nonprofit. Our tax ID number is 94-2495035. Our EIN number is 94-2495035.
Copyright 2022 all rights reserved.
Print Subscription
(The printed edition of the Gleams newsletter is only available if you live in the United States or Canada)
You can unsubscribe at any time. GRF will not share your personal information with any other organizations. Please see our Privacy Policy for further information.
E-mail Subscription
You can unsubscribe at any time. GRF will not share your personal information with any other organizations. Please see our Privacy Policy for further information.
